MwanzoAGIO • NASDAQ
add
Agios Pharmaceuticals Inc
Bei iliyotangulia
$ 33.42
Bei za siku
$ 32.90 - $ 33.73
Bei za mwaka
$ 23.42 - $ 62.58
Thamani ya kampuni katika soko
1.93B USD
Wastani wa hisa zilizouzwa
elfu 606.82
Uwiano wa bei na mapato
2.94
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 8.73M | 6.56% |
Matumizi ya uendeshaji wa biashara | 41.53M | 33.90% |
Mapato halisi | -89.29M | -9.49% |
Kiwango cha faida halisi | elfu -1.02 | -2.75% |
Mapato kwa kila hisa | -1.55 | -6.90% |
EBITDA | -105.35M | -16.12% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 893.38M | 49.40% |
Jumla ya mali | 1.56B | 83.06% |
Jumla ya dhima | 88.99M | -15.88% |
Jumla ya hisa | 1.47B | — |
hisa zilizosalia | 57.92M | — |
Uwiano wa bei na thamani | 1.32 | — |
Faida inayotokana na mali | -16.56% | — |
Faida inayotokana mtaji | -17.10% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -89.29M | -9.49% |
Pesa kutokana na shughuli | -111.49M | -11.64% |
Pesa kutokana na uwekezaji | 112.59M | -9.61% |
Pesa kutokana na ufadhili | 1.62M | -72.39% |
Mabadiliko halisi ya pesa taslimu | 2.72M | -91.11% |
Mtiririko huru wa pesa | -87.33M | -20.46% |
Kuhusu
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Ilianzishwa
2008
Tovuti
Wafanyakazi
487
